Fate Therapeutics (FATE) Other financing activities (2015 - 2024)
Fate Therapeutics' (FATE) quarterly Other financing activities came in at $18.1 million in Q4 2024, up 124.87% on a QoQ basis from -$72.6 million in Q3 2024.
Fate Therapeutics (FATE) Other financing activities (2015 - 2024) Analysis & Trends
Fate Therapeutics (FATE) has 9 years of Other financing activities data on file, last reported at $18.1 million in Q4 2024.
- Quarterly Other financing activities changed N/A year-over-year to $18.1 million in Q4 2024, while the trailing twelve-month figure through Sep 2025 was $18.1 million (up 830.72% YoY) and the FY2024 annual result came in at $20.0 million, changed N/A from the prior year.
- Other financing activities rose to $18.1 million in Q4 2024, from -$72.6 million in the prior quarter.
- In the past five years, Other financing activities ranged from a high of $75.2 million in Q1 2024 to a low of -$72.6 million in Q3 2024.
- A 5-year average of $1.6 million and a median of $1.5 million in 2022 frame the typical range for Other financing activities.
- Annual changes were most pronounced in 2020 — Other financing activities soared 7167.44% — and 2024, when it sank 27292.83%.
- Tracing FATE's Other financing activities over 5 years: stood at -$49.5 million in 2020, then soared by 65.13% to -$17.3 million in 2021, then jumped by 108.79% to $1.5 million in 2022, then plunged by 117.47% to -$265000.0 in 2023, then soared by 6913.58% to $18.1 million in 2024.
- The last three Other financing activities figures came in at $18.1 million (Q4 2024), -$72.6 million (Q3 2024), and -$662000.0 (Q2 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Fate Therapeutics | 298.82 Mn | 298.82 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 18.06 Mn |
| Dec 31, 2024 | 18.06 Mn |
| Sep 30, 2024 | -72.59 Mn |
| Sep 30, 2024 | -72.59 Mn |
| Jun 30, 2024 | -662,000.00 |
| Jun 30, 2024 | -662,000.00 |
| Mar 31, 2024 | 75.19 Mn |
| Mar 31, 2024 | 75.19 Mn |
| Sep 30, 2023 | -265,000.00 |
| Sep 30, 2023 | -265,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Jun 30, 2023 | 265,000.00 |
| Dec 31, 2022 | 1.52 Mn |
| Dec 31, 2022 | 1.52 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Sep 30, 2022 | 1.49 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Jun 30, 2022 | 3.41 Mn |
| Mar 31, 2022 | 2.80 Mn |
| Mar 31, 2022 | 2.80 Mn |